Tobi Podhaler is indicated for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa In adults and children aged 6 and over, suffering from cystic fibrosis.
Tobi Podhaler 28 mg: supply of supply until September 2025
The Viatris laboratory announces a stock rupture of the specialty Tobi Podhaler 28 mg, powder for inhalation in capsule (CIP 34009 499 132 9 9). A quota delivery is provided for the beginning of September 2025. This situation may affect the therapeutic management of the patients concerned, requiring temporary adaptation of treatment.
The alternative available: Tobi 300 mg/5 ml in solution for inhalation
In alternative, the TOBI 300 mg/5 ml specialty, solution for inhalation by nebulizer (CIP 34009 365 723 2 4), remains available. However, these two forms of tobi differ significantly in terms of pharmaceutical form, dosage, material used and mode of administration. In its information letter intended for health professionals, the Viatris laboratory joins a comparative table.
| Tobi 28 mg, powder for inhalation in capsule | Tobi 300 mg/5 ml, solution for inhalation by nebulizer | |
| Dosage | Each capsule contains 28 mg of Tobramycin. | Each 5 ml bulb contains a single 300 mg dose of Tobramycin. |
| Dosage | 4 capsules 2 times a day for 28 days. | 1 bulb twice a day for 28 days. |
| The two doses should be inhaled at an interval as close as possible to 12 hours and this interval should not be less than 6 hours. The plug is made in alternating cycles of 28 days of treatment followed by 28 days without treatment. | ||
| Material for inhalation | Podhaler inhaler only. | Reusable handbrick of LC Plus, equipped with an adapted compressor. |
| Mode d’administration | Insertion of the capsule years The inhalation chamber. Tobi Podhaler capsule must be inhaled with two inspiration maneuvers followed by apnea and must be checked in order to ensure that it is empty. | The bulb must be emptied in the nebulizer and the administration by inhalation must last approximately 15 minutes. The product must be inhaled by the patient in a sitting or standing position, breathing normally through the oral part of the nebulizer. Nasal pliers can help the patient breathe through the mouth. |
Patient support is essential when changing specialty in order to guarantee the good understanding of treatment and its effectiveness.
Contact Viatris for any additional information
For any questions relating to this situation or the terms of use of TOBI specialties, the Viatris medical information service can be reached online on the site www.viatrismiwebform.com or by phone on 0 800 123 550.
